Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
第一作者:
M,Rodgers
第一单位:
Centre for Reviews and Dissemination, University of York, York, UK.
作者:
医学主题词
消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);抗体, 单克隆(Antibodies, Monoclonal);抗风湿药(Antirheumatic Agents);关节炎, 牛皮癣(Arthritis, Psoriatic);成本及成本分析(Costs and Cost Analysis);人类(Humans);免疫球蛋白G(Immunoglobulin G);预后(Prognosis);质量校正寿命(Quality-Adjusted Life Years);受体, 肿瘤坏死因子(Receptors, Tumor Necrosis Factor);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)
DOI
10.3310/hta15100
PMID
21333232
发布时间
2025-05-29
基金项目
G0800770/MRC_/Medical Research Council/United Kingdom
MC_U105260557/MRC_/Medical Research Council/United Kingdom
- 浏览38
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



